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Previews
Xiong et al. (2004) to hypothesize that acidosis-mediatedIschemic Stroke:
activation of these channels contributes to ischemic“Acidotoxicity” Is a Perpetrator damage of brain tissue. Among the diverse members of
the ASIC family, they focused on ASIC1a in particular
for two reasons: it is highly expressed in the brain and
is activated by the levels of acidification detected inIschemic stroke is a devastating neurological disease.
ischemic brain tissue.The responsible mechanisms are not completely un-
Xiong and coauthors (2004) in this issue report thatderstood. In this issue of Cell, Xiong et al. (2004) eluci-
acidosis activates ASICs in mouse cortical neuronsdate a molecular mechanism by which acidosis dam-
in vitro. When studied at resting membrane potential,ages the brain during ischemia.
acidosis activated a depolarizing current mediated by
influx of cations; this required activation of ASIC1a inStroke is the third leading cause of death in the United
particular because this response was abolished in neu-States. Many of the survivors are saddled with lifelong,
rons cultured from ASIC1a/ mice. If neurons cultureddevastating neurological deficits. The majority of strokes
from wild-type mice were deprived of oxygen and glu-are “ischemic”; that is, blood supply to the brain is dis-
cose, thereby mimicking some features of ischemia, aci-rupted by a clot or other blockage. Current treatment
dosis resulted in a larger and more sustained current.of ischemic stroke is aimed at restoring blood supply
Interestingly, Ca2 permeated the acidosis-activatedby administration of thromobolytic drugs; only a small
channel and the influx of Ca2 contributed to acidosis-fraction of stroke victims receive these drugs because
induced death of neurons in vitro. Most importantly,they must be administered within three hours of stroke
limiting activation of ASICs reduced the damage pro-onset. The absence of effective neuroprotective drugs
duced by ischemia in vivo by approximately 60%, arenders the physician helpless to do anything other than
conclusion based on both pharmacological evidencewatch the often hideous consequences of an ischemic
and study of ASIC1a/ mice. Furthermore, the pharma-insult evolve.
cologic and genetic interventions limiting ASIC1 activa-Understanding the cellular and molecular mecha-
tion exerted neuroprotective effects even in the pres-
nisms by which ischemia destroys brain tissue may pro-
ence of a glutamate receptor antagonist. Quite simply,
vide drugs to minimize the damage. One mechanism
the authors have elucidated a molecular mechanism
that contributes to the exquisite sensitivity of brain to
by which acidosis damages the brain during ischemia,
ischemia is “excitotoxicity” (Choi, 1988). The amino acid
namely by activation of a specific membrane receptor
glutamate is the principal excitatory neurotransmitter in
and its resulting influx of Ca2.
the brain. Once released from a presynaptic terminal of Multiple molecular targets have been identified for
a neuron, glutamate diffuses across the synaptic cleft which neuroprotective therapies have been shown to
and binds to and activates one or more of a diversity be effective in animal models including nitric oxide syn-
of glutamate receptors in the target neuron, thereby thase, cannabinoid receptors, and many others. What
effecting its biologic responses. Ischemia results in loss sets apart the present work is the simple yet plausible
of ATP, which contributes to the paralysis of glutamate mechanism: the marked drop of pH damages the isch-
transporters that normally remove released glutamate emic tissue and does so by activation of this ASIC recep-
from the synaptic cleft. The resulting excess of gluta- tor. Importantly, the drop of pH in the core of the isch-
mate in the extracellular space leads to excessive acti- emic lesion raises the possibility that preventing
vation of glutamate receptors and pathological rises of activation of the ASIC receptor may reduce damage
[Ca2i]; the neuron is literally excited to death, leading to in the core, not simply in the partially ischemic tissue
the term “excitotoxicity”. Although effective in reducing surrounding the core that is targeted by most neuropro-
ischemic damage of brain tissue in animal models, gluta- tective treatments. Thus, the present discovery raises
mate receptor antagonists have not been effective in the exciting possibility that small molecules could be
clinical trials of stroke. Hopefully a fuller understanding developed to prevent acidosis-mediated activation of
of the pathology of ischemic stroke in molecular terms this receptor and thereby reduce ischemic injury.
will lead to more effective neuroprotective therapies. Enthusiasm for developing neuroprotective drugs tar-
That ischemia results in marked reductions of tissue geting ASICs must be tempered by lessons learned from
pH has been recognized for more than two decades failures of glutamate receptor antagonists in clinical tri-
(Rehncrona, 1985). Acidification of tissue is one conse- als for stroke. Lesson #1: glutamate receptor antago-
quence of oxygen depletion, which necessitates a nists were administered some hours (e.g., 4 to 8 hr) after
switch from aerobic metabolism to anaerobic glycolysis, onset of ischemic injury in the clinical trials; studies of
leading to generation of lactic acid as well as protons. animal models reveal that the greatest efficacy is evident
Importantly, the acidosis itself appears to worsen isch- when the antagonist is administered prior to stroke on-
emic brain injury (Tombaugh and Sapolsky, 1993; Siesjo set and efficacy diminishes quite rapidly if given more
et al., 1996); yet the mechanism of the deleterious effects than a couple of hours following onset of ischemia. In
of acidosis was unknown. The recent molecular cloning the present study, ASICs antagonists were administered
and characterization of acid-sensing ion channels (ASICs), prior to onset of ischemia and the decay of efficacy as
a function of time after ischemia was not examined.ion channels for which protons serve as the ligand, led
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Lesson #2: glutamate receptors mediate a diversity of All eukaryotic cells face a challenge of maintaining the
integrity of their genome despite continuous exposure tobrain functions under physiological conditions; thus,
environmental and metabolic insults that damage DNA.pharmacological blockade disrupts these normal func-
Some of these chemical and structural DNA modifica-tions, resulting in a diversity of unwanted effects includ-
tions are particularly deadly. For instance, DNA double-ing impaired learning and memory, psychosis, and oth-
strand breaks (DSBs) can destabilize the genome byers. This raises the important question as to what normal
promoting mutations and chromosomal rearrange-brain functions might be mediated by ASIC receptors.
ments. This undermines cell viability and, on the organis-Interestingly, earlier work from the Welsh laboratory re-
mal level, may lead to fatal diseases such as prematurevealed defects in synaptic plasticity, learning and mem-
aging or cancer.ory, and fear conditioning in ASIC1a/ mice (Wemmie
Given the danger of DSBs, it is not surprising that aet al., 2002, 2003). This raises the possibility that neuro-
large number of proteins, integrated into complex func-protective drugs targeting ASIC1a must somehow se-
tional networks, cooperate to rapidly detect and elimi-lectively block this receptor under pathological condi-
nate them (Shiloh, 2003). But how is the multifacetedtions in order to be tolerated in humans.
DSB response “choreographed” so that each molecularWhile sobering, these practical concerns for devel-
“dancer” involved knows when to arrive on the stage,oping neuroprotective therapies should not diminish
how long and with whom to perform, and when to givefrom the impressive achievement of the authors: identifi-
way to those that are scheduled to follow? Amazingly,cation of a molecular mechanism by which acidosis con-
nature has provided cells with a score for a fascinatingtributes to neuronal destruction in ischemic brain tissue.
play called “DNA repair.” Although we have known someIndeed their work moves “acidotoxicity” to the center
of the “dancers” for quite awhile, only now are we actu-stage in analyses of molecular mechanisms of ischemia.
ally beginning to see the performance unfold in front of
our eyes.
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powerful genetic manipulations in the budding yeast
Saccharomyces cerevisiae. They exchanged numerous
genes involved in DSB response by their replicas fused
to spectral variants of GFP, thereby preserving the en-
dogenous expression control, and studied redistributionWatching the DNA
of now “visible” DSB regulators in live yeast cells ex-Repair Ensemble Dance posed to ionizing radiation (IR, a known DSB inducer).
One could argue that similar strategies were applied
before (see, e.g., Melo et al., 2001), but what is so special
about the new study is the scale on which Lisby and
Repair of damaged DNA is a dynamic process that colleagues approached this task. The numerous yeast
requires careful orchestration of a multitude of en- strains generated during this monumental project al-
zymes, adaptor proteins, and chromatin constituents. lowed imaging of the DSB response in an unprece-
In this issue of Cell, Lisby et al. (2004) provide a visual dented breadth, from DSB recognition to homologous
glimpse into how the diverse signaling and repair ma- recombination (HR), the key mechanism to repair DSBs
chines are organized in space and time around the in yeast. And all this with an option to directly follow
deadliest genetic lesions—the DNA double-strand redistribution of the DSB regulators around the so-called
“repair centers,” the cytologically detectable nuclearbreaks.
